<div class="bodyItems-wrapper"> WASHINGTON (AP) — The Food and Drug Administration said Friday it will add a new warning and other limitations to a <a href="https://apnews.com/article/sarepta-death-patient-duchennes-muscular-dystrophy-7ee6fc7b1e5e70667c638b598145a5f9" rel="nofollow noopener" target="_blank" data-ylk="slk:gene therapy for Duchenne’s muscular dystrophy;elm:context_link;itc:0;sec:content-canvas" class="link ">gene therapy for Duchenne’s muscular dystrophy</a> that's been linked to <a href="https://apnews.com/article/sarepta-muscular-dystophy-duchennes-gene-therapy-255d04aa3db9bd171c9bf006328ba5d3" rel="nofollow noopener" target="_blank" data-ylk="slk:two patient deaths;elm:context_link;itc:0;sec:content-canvas" class="link ">two patient deaths</a>. The infused therapy from Sarepta Therapeutics will carry a boxed warning — the most serious type — alerting doctors and patients to the risk of potentially fatal liver failure with the treatment, the FDA said in a release. The one-time therapy, Elevidys, has been under <a href="https://apnews.com/article/sarepta-muscular-dystophy-death-fda-gene-therapy-756b7ef43591b685fc197d6acb29c4c1" rel="nofollow noopener" target="_blank" data-ylk="slk:FDA scrutiny;elm:context_link;itc:0;sec:content-canvas" class="link ">FDA scrutiny</a> since the company reported the first of two deaths of teenage boys in March. Following a second death reported in June, the FDA briefly called for halting all shipments of the drug. But the agency quickly <a href="https://apnews.com/article/sarepta-muscular-dystophy-death-fda-gene-therapy-0cab4d676c93f679b7b35d9830b2b57d" rel="nofollow noopener" target="_blank" data-ylk="slk:reversed course;elm:context_link;itc:0;sec:content-canvas" class="link ">reversed course</a> after facing pushback from patient families and <a href="https://apnews.com/article/vinay-prasad-fda-vaccines-laura-loomer-83030ad6eb7651095e3c40444dd69f12" rel="nofollow noopener" target="_blank" data-ylk="slk:libertarian activists;elm:context_link;itc:0;sec:content-canvas" class="link ">libertarian activists</a> close to President Donald Trump. Elevidys is the first U.S.-approved <a href="https://apnews.com/article/fda-gene-therapy-duchenne-muscular-dystrophy-approval-82a82cfb67ef9fb6cf75cd3b5865c138" rel="nofollow noopener" target="_blank" data-ylk="slk:gene therapy;elm:context_link;itc:0;sec:content-canvas" class="link ">gene therapy</a> for Duchenne’s muscular dystrophy, a fatal muscle-wasting disease that affects boys and young men. In addition to the boxed warning, the FDA is also limiting the drug's approved use to patients who are 4 years old and up and can still walk. Previously the FDA had allowed the drug's use in immobile patients, who generally have more advanced disease. New labeling will also recommend weekly liver function monitoring for the first three months of treatment, as well as other precautionary steps. Elevidys is Sarepta's best-selling product and recent headwinds against the drug have weighed heavily on the company and its stock. In July, the Cambridge, Massachusetts-based company announced it would lay off 500 employees. Sarepta Therapeutics Inc. shares rose 7.7% in trading after the FDA announcement, reflecting improved visibility for investors about the company's outlook. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. </div>

The Food and Drug Administration said Friday it will add a new warning and other limitations to a gene therapy for Duchenne’s muscular dystrophy that's been linked to two patient deaths.  The infused therapy from Sarepta Therapeutics will carry a boxed warning — the most serious type — alerting doctors and patients to the risk of potentially fatal liver failure with the treatment, the FDA said in a release.  The one-time therapy, Elevidys, has been under FDA scrutiny since the company reported t

FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths

The pair were among six people who were saved in three separate water-related incidents in Victoria, Australia, on Dec. 25

Mother and Stepson Rescued After Being Swept Over 6 Miles in Paddleboarding Mishap

The basic demonstration of flossing assumes an instrumental part in forestalling gum illness and keeping up with ideal oral wellbeing. While it


Instructions to Floss Appropriately and Forestall Gum Sickness


A British court ruled Friday that Australian mining giant BHP is liable for one of Brazil's worst environmental disasters, potentially paving the way for billions of dollars in compensation. BHP on Friday said it would appeal the ruling.

BHP liable for 2015 Brazil mine disaster: UK court

The monarch was diagnosed with cancer in 2024.

King Charles III says he is reducing cancer treatment schedule in 2026

A paraplegic engineer from Germany blasted off on a dream-come-true rocket ride with five other passengers Saturday, leaving her wheelchair behind to float in space while beholding Earth from on high.  Severely injured in a mountain bike accident seven years ago, Michaela Benthaus became the first wheelchair user in space, launching from West Texas with Jeff Bezos’ company Blue Origin.  An ecstatic Benthaus said she laughed all the way up — the capsule soared more than 65 miles (105 kilometers)

Paraplegic engineer becomes the first wheelchair user to blast into space

Kennedy is one of about 50,000 Americans who have spasmodic dysphonia.

What causes RFK Jr.’s strained and shaky voice? A neurologist explains this little-known disorder

LONDON, Dec 10 () - Roche said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by ​30% compared with standard endocrine therapy, in what it said marked ‌the first big advance in hormonal treatment for the disease in over 20 years. The Swiss ‌drugmaker said detailed results from the phase III lidERA trial showed at three years, 92.

Roche breast cancer pill cuts risk of disease recurrence by 30% in trial

'Tis the season for sniffling, coughing and calling out of work. Here's what to know about the pathogens circulating in the U.S. this December.

What's going around right now? COVID, flu, stomach bug on the rise

Thor was last seen in "Thor: Love and Thunder" in 2022.

A somber Thor is returning for 'Avengers: Doomsday': Watch the dread-filled teaser

Discussion is a major expertise in both individual and expert life. It engages people to advocate for their inclinations, reach


Excelling at Discussion: Genuine Examples of overcoming adversity


For golf lovers looking for a definitive encounter, very good quality fairways all over the planet offer stunning scenes, testing plans, and rich


Very good quality Greens All over The Planet


Setting out on a stream voyage is a door to a phenomenal embroidery of social, verifiable, and regular fortunes. The backbone


Figure out How to Improve Your Stream Voyage with Remarkable Trips and Exercises


Broiled chicken is a dearest solace food that has turned into a staple in numerous nations all over the planet. Each seared chicken chain has its own interesting recipe and style, making it a #1 for various re


Most loved Seared Chicken: Which Chain Rules?


Nec consectetur quis, elementum eu arcu. Nunc ornare arcu lacus, quis aliquet odio bibendum non. Nam vitae libero mauris. Suspendisse vitae purus ligula. Morbi sed diam eget dolor posuere convallis vel nisl. Nulla sagittis efficitur ex, at sodales massa pulvinar a. Nunc quis lacinia eros. Fusce ac ipsum gravida, tristique sed felis augue announcement.
